Improved Glucose Metabolism In Vitro and In Vivo by an Allosteric Monoclonal Antibody That Increases Insulin Receptor Binding Affinity

• John A. Corbin ,

  * E-mail: corbinjohn@gmail.com

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Vinay Bhaskar,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Ira D. Goldfine,

  Affiliation Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Daniel H. Bedinger,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Angela Lau,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Kristen Michelson,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Lisa M. Gross,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Betty A. Maddux,

  Affiliation Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Hua F. Kuan,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Catarina Tran,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Llewelyn Lao,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Masahisa Handa,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Susan R. Watson,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Ajay J. Narasimha,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Shirley Zhu,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Raphael Levy,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Lynn Webster,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Sujeewa D. Wijesuriya,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Naichi Liu,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Xiaorong Wu,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• David Chemla-Vogel,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Steve R. Lee,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Steve Wong,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• Diane Wilcock,

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
•  [ ... ],
• Mark L. White

  Affiliation Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America

  ⨯
• [ view all ]
• [ view less ]